See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626971_2024_Corvus_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001626971, Corvus Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 27,956,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 236,000 |
| 3 | remainder_Assets | 17,361,000 |
| 4 | LiabilitiesCurrent | 6,869,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,304,505 |
| 9 | ResearchAndDevelopmentExpense | 12,345,003 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -5,213,627 |
| 13 | remainder_ComprehensiveNetIncome | -1,528,279 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 45,553,000 |
| 1 | Liabilities | 6,869,000 |
| 2 | Expenses | 18,649,508 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 38,684,000 |
| 5 | NetIncome | -23,863,135 |
| 6 | ComprehensiveNetIncome | -24,627,274 |
| 7 | BaseVar | 38,906,707 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.28 |
| 9 | EconomicCapitalRatio | 3.21 |
Edgar->Model Mapping
Feature Distribution
Change over Time
